4.3 Article

Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis

E. J. Fox et al.

EUROPEAN JOURNAL OF NEUROLOGY (2012)

Article Ophthalmology

Subclinical optic neuropathy in multiple sclerosis

Tine Engell et al.

ACTA OPHTHALMOLOGICA (2009)

Article Medicine, General & Internal

Alemtuzumab vs. Interferon beta-1a in early multiple sclerosis

Alasdair J. Coles et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Clinical Neurology

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis

L. J. Balcer et al.

NEUROLOGY (2007)

Article Clinical Neurology

Geniculate quadruple sectoranopia

Benjamin J. Osborne et al.

NEUROLOGY (2006)

Article Clinical Neurology

The window of therapeutic opportunity in multiple sclerosis

AJ Coles et al.

JOURNAL OF NEUROLOGY (2006)

Review Clinical Neurology

The neuro-ophthalmology of multiple sclerosis

EM Frohman et al.

LANCET NEUROLOGY (2005)

Article Clinical Neurology

Asymptomatic visual loss in multiple sclerosis

J Lycke et al.

JOURNAL OF NEUROLOGY (2001)

Article Geriatrics & Gerontology

Visual risk factors for falls in older people

SR Lord et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2001)

Article Ergonomics

Visual risk factors for driving difficulty among older drivers

G McGwin et al.

ACCIDENT ANALYSIS AND PREVENTION (2000)

Article Geriatrics & Gerontology

Visual contributions to postural stability in older adults

SR Lord et al.

GERONTOLOGY (2000)